Go Pro
→ Trump's gold order: the announcement they won't put on the front page (From Reagan Gold Group) (Ad)tc pixel Free INGN Stock Alerts

Inogen (INGN) Financials

Inogen logo
$6.67 +0.07 (+1.06%)
Closing price 07/6/2026 04:00 PM Eastern
Extended Trading
$6.67 0.00 (0.00%)
As of 07/6/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Inogen

Annual Income Statements for Inogen

This table shows Inogen's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 12 21 21 409 216 -5.83 -6.33 -84 -102 -36 -23
Consolidated Net Income / (Loss)		 12 21 21 52 21 -5.83 -6.33 -84 -102 -36 -23
Net Income / (Loss) Continuing Operations		 12 21 21 409 217 -5.83 -6.33 -84 -102 -36 -23
Total Pre-Tax Income 		15 23 30 40 24 -5.28 8.66 -83 -102 -36 -23
Total Operating Income		 15 23 28 38 20 -12 9.24 -85 -109 -43 -30
Total Gross Profit		 76 97 121 357 172 138 176 154 127 155 154
Total Revenue		 159 203 249 537 724 308 358 377 316 336 349
Operating Revenue		 159 203 249 537 724 308 358 377 316 336 349
Total Cost of Revenue		 83 106 128 180 208 170 182 224 189 181 194
Operating Cost of Revenue		 83 106 128 180 208 170 182 224 189 181 194
Total Operating Expenses		 61 74 94 -38 304 150 167 239 236 197 184
Selling, General & Admin Expense		 26 32 38 38 37 39 38 44 75 73 67
Marketing Expense		 31 38 51 96 106 98 113 121 107 103 98
Research & Development Expense		 4.18 5.11 5.31 7.03 9.40 14 17 22 21 22 19
Impairment Charge		 - - - - - - 0.00 0.00 33 0.00 0.00
Total Other Income / (Expense), net		 -0.32 -0.14 2.07 2.56 8.97 6.75 -0.58 1.98 7.04 6.04 6.83
Interest & Investment Income		 0.10 0.20 0.77 3.26 4.71 0.91 0.13 2.84 6.57 5.19 4.39
Other Income / (Expense), net		 -0.40 -0.33 1.30 -0.70 4.25 5.84 -0.71 -0.86 0.47 0.85 2.44
Income Tax Expense		 3.14 2.21 8.65 -11 3.32 0.55 15 0.50 0.11 -0.59 -0.63
Basic Earnings per Share		 $0.60 $1.02 $1.02 $2.44 $0.96 ($0.27) ($0.28) ($3.67) ($4.42) ($1.52) ($0.86)
Weighted Average Basic Shares Outstanding		 19.40M 20.07M 20.68M 21.27M 21.82M 21.98M 22.49M 22.85M 23.18M 23.65M 26.60M
Diluted Earnings per Share		 $0.56 $0.97 $0.96 $2.30 $0.94 ($0.27) ($0.28) ($3.67) ($4.42) ($1.52) ($0.86)
Weighted Average Diluted Shares Outstanding		 20.71M 21.10M 21.90M 22.51M 22.24M 21.98M 22.49M 22.85M 23.18M 23.65M 26.60M
Weighted Average Basic & Diluted Shares Outstanding		 19.30M 20.10M 20.60M 21.81M 21.82M 21.98M 22.49M 22.97M 23.33M 26.53M 27.23M

Quarterly Income Statements for Inogen

This table shows Inogen's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -46 -27 -15 -5.59 -5.96 -9.76 -6.17 -4.15 -5.29 -7.13 -8.32
Consolidated Net Income / (Loss)		 -46 -27 -15 -5.59 -5.96 -9.76 -6.17 -4.15 -5.29 -7.13 -8.32
Net Income / (Loss) Continuing Operations		 -46 -27 -15 -5.59 -5.96 -9.76 -6.17 -4.15 -5.29 -7.13 -8.32
Total Pre-Tax Income 		-45 -27 -15 -5.60 -6.06 -10 -6.27 -4.31 -5.44 -7.36 -8.50
Total Operating Income		 -47 -29 -16 -7.06 -7.79 -11 -7.66 -6.13 -7.12 -9.31 -9.34
Total Gross Profit		 34 28 34 43 41 36 36 41 41 35 38
Total Revenue		 84 76 78 89 89 80 82 92 92 82 85
Operating Revenue		 84 76 78 89 89 80 82 92 92 82 85
Total Cost of Revenue		 50 48 44 46 47 44 46 51 51 46 47
Operating Cost of Revenue		 50 48 44 46 47 44 46 51 51 46 47
Total Operating Expenses		 80 57 51 50 49 48 44 47 48 45 47
Selling, General & Admin Expense		 17 25 17 19 19 18 16 17 18 16 17
Marketing Expense		 26 26 27 26 26 24 24 25 25 23 25
Research & Development Expense		 4.49 6.71 6.58 5.62 3.52 5.90 4.03 5.21 4.84 5.32 5.10
Total Other Income / (Expense), net		 1.40 1.89 1.55 1.47 1.73 1.30 1.39 1.82 1.68 1.94 0.84
Interest & Investment Income		 1.80 1.60 1.40 1.33 1.04 1.41 1.03 1.12 1.07 1.16 0.88
Other Income / (Expense), net		 -0.40 0.29 0.14 0.13 0.69 -0.11 0.36 0.70 0.61 0.78 -0.04
Income Tax Expense		 0.40 -0.53 -0.15 -0.01 -0.10 -0.33 -0.10 -0.15 -0.15 -0.24 -0.17
Basic Earnings per Share		 ($1.97) ($1.15) ($0.62) ($0.24) ($0.25) ($0.41) ($0.25) ($0.15) ($0.20) ($0.26) ($0.30)
Weighted Average Basic Shares Outstanding		 23.23M 23.18M 23.40M 23.61M 23.75M 23.65M 25.16M 26.96M 27.08M 26.60M 27.32M
Diluted Earnings per Share		 ($1.97) ($1.15) ($0.62) ($0.24) ($0.25) ($0.41) ($0.25) ($0.15) ($0.20) ($0.26) ($0.30)
Weighted Average Diluted Shares Outstanding		 23.23M 23.18M 23.40M 23.61M 23.75M 23.65M 25.16M 26.96M 27.08M 26.60M 27.32M
Weighted Average Basic & Diluted Shares Outstanding		 23.31M 23.33M 23.58M 23.72M 23.82M 26.53M 26.89M 27.04M 27.15M 27.23M 27.07M

Annual Cash Flow Statements for Inogen

This table details how cash moves in and out of Inogen's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 9.27 27 50 54 1.40 14 24 -49 -62 -8.08 -12
Net Cash From Operating Activities		 38 31 60 60 41 37 24 -38 -3.23 5.91 -11
Net Cash From Continuing Operating Activities		 38 31 60 60 41 37 24 -38 -3.23 5.91 -11
Net Income / (Loss) Continuing Operations		 12 21 21 52 21 -5.83 -6.33 -84 -102 -36 -23
Consolidated Net Income / (Loss)		 12 21 21 52 21 -5.83 -6.33 -84 -102 -36 -23
Depreciation Expense		 14 14 12 11 14 19 22 24 18 21 21
Non-Cash Adjustments To Reconcile Net Income		 23 32 33 37 27 25 25 92 67 30 24
Changes in Operating Assets and Liabilities, net		 -10 -35 -5.38 -41 -21 -1.20 -17 -70 14 -9.00 -33
Net Cash From Investing Activities		 -29 -12 -24 -25 -44 -26 -15 -11 -59 -14 -26
Net Cash From Continuing Investing Activities		 -29 -12 -24 -25 -44 -26 -15 -11 -59 -14 -26
Purchase of Property, Plant & Equipment		 -2.21 -1.72 -2.91 -8.04 -3.14 -4.39 -5.48 -3.34 -5.22 -3.36 -2.52
Acquisitions		 -0.05 -0.11 -7.81 -0.35 -71 -0.26 -0.13 0.00 -30 -2.09 0.00
Purchase of Investments		 -37 -33 -47 -76 -59 -23 -9.99 0.00 -27 -33 -30
Sale of Property, Plant & Equipment		 - 0.39 0.18 0.72 0.19 0.16 0.15 0.33 0.20 0.28 0.00
Sale and/or Maturity of Investments		 20 29 37 63 91 15 19 10 24 36 14
Other Investing Activities, net		 -10 -6.19 -4.00 -4.58 -3.12 -13 -18 -18 -21 -12 -7.86
Net Cash From Financing Activities		 0.38 7.71 14 18 4.93 2.07 15 0.38 0.96 0.27 24
Net Cash From Continuing Financing Activities		 0.38 7.71 14 18 4.93 2.07 15 0.38 0.96 0.27 24
Issuance of Common Equity		 0.70 1.06 1.38 2.35 2.75 2.08 1.95 1.69 1.09 0.81 28
Other Financing Activities, net		 -0.03 6.97 13 16 2.18 -0.02 13 -1.31 -0.13 -0.55 -4.00
Effect of Exchange Rate Changes		 - - - - -0.06 - - -0.48 0.07 -0.28 0.85
Cash Income Taxes Paid		 0.02 -0.45 1.27 1.65 0.24 -0.71 1.54 0.50 -0.70 0.38 0.32

Quarterly Cash Flow Statements for Inogen

This table details how cash moves in and out of Inogen's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -43 0.88 -18 -5.97 7.80 8.13 5.12 -18 2.80 -2.74 -11
Net Cash From Operating Activities		 2.19 -3.15 -4.75 6.69 6.99 -3.02 -17 4.35 2.17 -0.94 -6.69
Net Cash From Continuing Operating Activities		 2.19 -3.15 -4.75 6.69 6.99 -3.02 -17 4.35 2.17 -0.94 -6.69
Net Income / (Loss) Continuing Operations		 -46 -27 -15 -5.59 -5.96 -9.76 -6.17 -4.15 -5.29 -7.13 -8.32
Consolidated Net Income / (Loss)		 -46 -27 -15 -5.59 -5.96 -9.76 -6.17 -4.15 -5.29 -7.13 -8.32
Depreciation Expense		 4.61 5.14 5.27 5.35 5.31 5.08 5.19 5.22 5.22 5.04 4.90
Non-Cash Adjustments To Reconcile Net Income		 43 8.19 7.45 6.04 7.46 8.85 5.56 6.83 6.43 5.47 5.88
Changes in Operating Assets and Liabilities, net		 -0.17 10 -2.89 0.89 0.18 -7.19 -21 -3.54 -4.19 -4.32 -9.15
Net Cash From Investing Activities		 -46 4.13 -13 -12 0.31 12 -2.04 -23 -0.08 -1.52 -1.98
Net Cash From Continuing Investing Activities		 -46 4.13 -13 -12 0.31 12 -2.04 -23 -0.08 -1.52 -1.98
Purchase of Property, Plant & Equipment		 -0.71 -1.39 -1.31 -0.05 -1.67 -0.33 -0.29 -0.68 -0.57 -0.98 -0.21
Purchase of Investments		 -11 -3.12 -12 -20 -0.00 -0.32 0.00 -19 -3.98 -7.15 -5.86
Sale and/or Maturity of Investments		 - 14 3.00 13 5.00 15 0.00 - 6.00 8.00 4.67
Other Investing Activities, net		 -4.58 -4.91 -2.82 -2.83 -3.18 -2.81 -1.75 -3.19 -1.54 -1.39 -0.57
Net Cash From Financing Activities		 0.45 -0.01 0.29 -0.20 0.44 -0.26 24 - 0.42 -0.19 -2.12
Net Cash From Continuing Financing Activities		 0.45 -0.01 0.29 -0.20 0.44 -0.26 24 - 0.42 -0.19 -2.12
Repurchase of Common Equity		 - - - - - - 0.00 - - - -1.87
Issuance of Common Equity		 0.46 - 0.37 - 0.44 - 28 - 0.48 - 0.37
Other Financing Activities, net		 -0.02 -0.01 -0.09 -0.20 - -0.26 -3.75 - -0.06 -0.19 -0.62
Effect of Exchange Rate Changes		 - -0.08 -0.14 -0.08 0.06 -0.13 0.00 0.64 0.30 -0.09 0.17
Cash Income Taxes Paid		 -1.16 0.04 0.42 0.06 -0.14 0.03 0.40 0.08 -0.16 0.00 0.45

Annual Balance Sheets for Inogen

This table presents Inogen's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 161 214 275 376 447 462 490 405 326 296 299
Total Current Assets		 115 162 228 315 292 306 329 305 207 185 198
Cash & Equivalents		 66 93 143 197 198 212 236 187 125 114 104
Restricted Cash		 - - - - - - - - 0.00 3.62 1.29
Short-Term Investments		 17 21 31 44 11 19 9.99 0.00 2.98 0.00 16
Accounts Receivable		 20 31 31 37 34 30 24 63 42 30 39
Inventories, net		 8.65 14 19 27 36 25 32 34 22 25 26
Prepaid Expenses		 0.87 1.66 2.58 7.47 10 18 26 19 14 14 13
Current Deferred & Refundable Income Taxes		 2.16 0.43 1.31 2.66 2.98 2.05 1.34 1.63 0.67 0.00 0.00
Plant, Property, & Equipment, net		 31 25 20 22 19 28 39 43 50 44 36
Total Noncurrent Assets		 16 27 26 39 136 128 121 57 69 66 64
Goodwill		 - - 2.36 2.26 33 33 33 33 10 9.47 11
Intangible Assets		 0.23 0.24 4.72 3.76 78 69 60 0.18 35 30 31
Other Noncurrent Operating Assets		 0.10 0.41 0.77 2.83 11 11 28 24 24 26 23
Total Liabilities & Shareholders' Equity		 161 214 275 376 447 462 490 405 326 296 299
Total Liabilities		 27 32 48 65 103 112 119 108 121 122 106
Total Current Liabilities		 22 23 34 47 50 57 62 65 72 77 64
Accounts Payable		 13 13 21 27 31 34 26 34 30 27 34
Accrued Expenses		 1.23 1.69 2.51 3.55 4.92 5.74 6.48 7.79 9.63 9.74 10
Current Deferred Revenue		 2.32 2.24 3.53 4.45 5.48 6.99 8.57 8.88 7.98 6.65 5.50
Current Deferred & Payable Income Tax Liabilities		 0.01 - 0.35 0.39 0.82 1.24 0.08 0.00 0.03 0.14 0.18
Current Employee Benefit Liabilities		 5.27 6.12 6.88 11 6.22 7.09 17 11 11 17 11
Other Current Liabilities		 - - - - 2.01 1.93 3.39 3.52 14 16 3.16
Total Noncurrent Liabilities		 5.28 9.12 14 19 53 56 58 42 49 46 43
Noncurrent Deferred Revenue		 4.20 7.04 9.40 12 14 12 12 10 8.23 5.75 3.60
Noncurrent Deferred & Payable Income Tax Liabilities		 - - 0.35 0.23 0.09 0.03 0.00 0.00 8.54 6.95 6.75
Other Noncurrent Operating Liabilities		 1.08 2.07 4.40 6.81 39 44 46 32 32 33 33
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 134 182 227 310 345 350 370 297 205 174 192
Total Preferred & Common Equity		 134 182 227 310 345 350 370 297 205 174 192
Total Common Equity		 134 182 227 310 345 350 370 297 205 174 192
Common Stock		 179 194 218 249 263 274 299 312 321 328 364
Retained Earnings		 -45 -12 8.64 60 81 76 69 -15 -117 -153 -176
Accumulated Other Comprehensive Income / (Loss)		 -0.04 -0.04 0.27 0.72 -0.09 0.48 1.47 -0.24 1.23 -1.50 4.24

Quarterly Balance Sheets for Inogen

This table presents Inogen's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 344 316 309 306 308 312 307 286
Total Current Assets		 225 199 195 193 201 203 204 191
Cash & Equivalents		 125 107 98 106 119 104 106 93
Restricted Cash		 - - 3.56 3.59 3.65 1.27 1.28 1.30
Short-Term Investments		 13 12 20 15 0.00 19 17 17
Accounts Receivable		 48 40 36 34 37 39 40 42
Inventories, net		 24 25 24 23 26 24 25 25
Prepaid Expenses		 14 14 12 9.78 15 17 14 12
Current Deferred & Refundable Income Taxes		 0.47 0.98 1.05 0.96 0.00 0.00 0.00 0.00
Plant, Property, & Equipment, net		 50 49 47 47 41 40 37 34
Total Noncurrent Assets		 69 67 67 67 67 69 66 62
Goodwill		 9.87 9.83 9.76 10 9.86 11 11 10
Intangible Assets		 34 33 34 34 32 33 32 29
Other Noncurrent Operating Assets		 25 24 24 23 25 25 23 22
Total Liabilities & Shareholders' Equity		 344 316 309 306 308 312 307 286
Total Liabilities		 113 124 121 121 110 113 110 103
Total Current Liabilities		 60 74 72 72 65 67 65 61
Accounts Payable		 30 32 27 27 36 35 34 33
Accrued Expenses		 9.03 10 9.76 9.49 9.66 9.74 9.79 9.98
Current Deferred Revenue		 8.48 7.42 7.39 6.98 6.41 6.26 5.97 5.09
Current Deferred & Payable Income Tax Liabilities		 0.20 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Current Employee Benefit Liabilities		 8.37 11 14 14 11 13 12 10
Other Current Liabilities		 3.89 14 15 15 2.95 3.08 3.12 3.49
Total Noncurrent Liabilities		 53 50 49 48 45 45 45 42
Noncurrent Deferred Revenue		 8.88 7.61 7.07 6.44 5.11 4.59 4.08 3.17
Noncurrent Deferred & Payable Income Tax Liabilities		 8.42 8.15 8.07 8.38 7.41 7.95 7.89 6.57
Other Noncurrent Operating Liabilities		 35 34 34 34 32 33 33 32
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 231 192 188 185 198 199 197 183
Total Preferred & Common Equity		 231 192 188 185 198 199 197 183
Total Common Equity		 231 192 188 185 198 199 197 183
Common Stock		 322 323 325 327 357 360 362 363
Retained Earnings		 -90 -132 -137 -143 -159 -163 -168 -184
Accumulated Other Comprehensive Income / (Loss)		 -0.58 0.19 -0.14 1.72 -0.51 2.89 3.68 3.42

Annual Metrics And Ratios for Inogen

This table displays calculated financial ratios and metrics derived from Inogen's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 19,652,273.00 20,260,695.00 20,870,357.00 21,522,602.00 21,998,485.00 22,117,647.00 22,724,098.00 22,921,002.00 23,307,814.00 - 27,148,482.00
DEI Adjusted Shares Outstanding		 19,652,273.00 20,260,695.00 20,870,357.00 21,522,602.00 21,998,485.00 22,117,647.00 22,724,098.00 22,921,002.00 23,307,814.00 - 27,148,482.00
DEI Earnings Per Adjusted Shares Outstanding		 0.59 1.01 1.01 19.00 9.80 -0.26 -0.28 -3.65 -4.40 - -0.84
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 41.29% 27.56% 22.98% 115.16% 34.88% -57.38% 16.05% 5.37% -16.32% 6.35% 3.86%
EBITDA Growth		 27.15% 25.94% 14.13% 17.72% -21.89% -67.28% 143.37% -307.54% -45.01% 77.24% 65.61%
EBIT Growth		 40.04% 53.85% 28.21% 28.75% -35.36% -125.74% 237.83% -1,109.44% -26.49% 61.75% 33.37%
NOPAT Growth		 65.88% 74.36% -5.36% 148.53% -64.83% -149.28% 19.72% -782.96% -28.32% 61.13% 28.95%
Net Income Growth		 69.72% 77.12% 2.35% 146.86% -59.59% -127.82% -8.65% -1,222.79% -22.30% 64.97% 36.62%
EPS Growth		 86.67% 73.21% -1.03% 139.58% -59.13% -128.72% -3.70% -1,210.71% -20.44% 65.61% 43.42%
Operating Cash Flow Growth		 143.11% -18.68% 94.93% -0.85% -32.32% -8.82% -36.15% -258.81% 91.38% 282.87% -289.65%
Free Cash Flow Firm Growth		 1,738.21% -82.65% 794.20% -8.84% -253.16% 118.00% -250.11% -247.02% 6.24% 76.80% -265.58%
Invested Capital Growth		 -16.95% 32.60% -22.15% 31.98% 93.40% -12.63% 5.33% -11.48% -30.85% -26.06% 26.43%
Revenue Q/Q Growth		 7.67% 5.41% 5.47% 60.03% 32.06% -56.78% 12.86% 3.20% -3.72% 1.26% 0.47%
EBITDA Q/Q Growth		 8.30% 6.50% -1.18% -2.20% -8.28% -26.09% -2.58% -442.90% 24.00% 45.32% 29.19%
EBIT Q/Q Growth		 15.39% 12.36% -0.92% -2.16% -17.96% -310.96% -16.12% -147.20% 21.31% 29.21% 9.68%
NOPAT Q/Q Growth		 25.48% 8.21% -24.41% 24.40% -39.38% -1.70% -158.89% -155.01% 21.24% 29.27% 6.44%
Net Income Q/Q Growth		 25.30% 7.33% -21.83% 25.86% -35.28% -179.84% -155.44% -67.41% 22.68% 31.88% 10.36%
EPS Q/Q Growth		 19.15% 6.59% -21.31% 25.00% -34.72% -200.00% -158.33% -67.58% 23.13% 32.74% 14.85%
Operating Cash Flow Q/Q Growth		 27.49% -19.20% 14.86% -1.11% -6.77% 22.54% -29.10% -141.33% 79.23% 2.25% 15.61%
Free Cash Flow Firm Q/Q Growth		 91.79% -85.89% 123.90% 5.89% -3.10% 289.82% -462.06% -141.01% 12.52% 7.27% -5.69%
Invested Capital Q/Q Growth		 -8.47% 42.62% -8.76% 3.96% -4.89% -10.29% -14.46% -21.82% -17.55% -7.69% -1.80%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 47.96% 47.98% 48.60% 66.55% 23.74% 44.79% 49.30% 40.70% 40.14% 46.09% 44.24%
EBITDA Margin		 18.02% 17.79% 16.51% 9.04% 5.23% 4.02% 8.42% -16.59% -28.75% -6.15% -2.04%
Operating Margin		 9.47% 11.27% 11.06% 7.06% 2.73% -3.90% 2.58% -22.60% -34.65% -12.66% -8.66%
EBIT Margin		 9.21% 11.11% 11.58% 6.93% 3.32% -2.01% 2.38% -22.82% -34.50% -12.41% -7.96%
Profit (Net Income) Margin		 7.29% 10.12% 8.42% 9.66% 2.89% -1.89% -1.77% -22.21% -32.46% -10.69% -6.52%
Tax Burden Percent		 78.67% 90.29% 70.82% 128.15% 86.31% 110.40% -73.14% 100.61% 100.10% 98.39% 97.30%
Interest Burden Percent		 100.55% 100.84% 102.65% 108.76% 100.95% 85.31% 101.51% 96.71% 93.96% 87.54% 84.21%
Effective Tax Rate		 21.34% 9.71% 29.18% -28.15% 13.69% 0.00% 173.14% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 20.89% 34.51% 32.22% 78.85% 16.62% -6.63% -5.56% -50.76% -82.01% -44.83% -33.09%
ROIC Less NNEP Spread (ROIC-NNEP)		 21.26% 34.64% 31.20% 77.26% 14.89% -7.81% -5.74% -39.62% -65.60% -39.84% -31.74%
Return on Net Nonoperating Assets (RNNOA)		 -11.70% -21.53% -21.95% -59.56% -10.22% 4.95% 3.80% 25.66% 41.21% 25.87% 20.66%
Return on Equity (ROE)		 9.19% 12.98% 10.27% 19.29% 6.40% -1.68% -1.76% -25.10% -40.80% -18.95% -12.43%
Cash Return on Invested Capital (CROIC)		 39.40% 6.48% 57.12% 51.28% -47.05% 6.86% -10.75% -38.58% -45.54% -14.86% -56.44%
Operating Return on Assets (OROA)		 9.72% 12.01% 11.81% 11.43% 5.84% -1.36% 1.79% -19.25% -29.79% -13.39% -9.34%
Return on Assets (ROA)		 7.69% 10.93% 8.59% 15.93% 5.09% -1.28% -1.33% -18.73% -28.02% -11.53% -7.65%
Return on Common Equity (ROCE)		 9.19% 12.98% 10.27% 19.29% 6.40% -1.68% -1.76% -25.10% -40.80% -18.95% -12.43%
Return on Equity Simple (ROE_SIMPLE)		 8.64% 11.27% 9.25% 16.70% 6.08% -1.67% -1.71% -28.17% 0.00% -20.64% 0.00%
Net Operating Profit after Tax (NOPAT)		 12 21 20 49 17 -8.42 -6.76 -60 -77 -30 -21
NOPAT Margin		 7.45% 10.18% 7.83% 9.05% 2.36% -2.73% -1.89% -15.82% -24.26% -8.87% -6.06%
Net Nonoperating Expense Percent (NNEP)		 -0.37% -0.13% 1.02% 1.59% 1.72% 1.18% 0.18% -11.14% -16.41% -4.98% -1.34%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -20.06% -37.39% -17.12% -11.00%
Cost of Revenue to Revenue		 52.04% 52.02% 51.40% 33.45% 28.78% 55.21% 50.70% 59.30% 59.86% 53.91% 55.76%
SG&A Expenses to Revenue		 16.14% 15.67% 15.06% 7.08% 5.13% 12.51% 10.57% 11.64% 23.84% 21.62% 19.33%
R&D to Revenue		 2.63% 2.52% 2.13% 1.31% 1.30% 4.56% 4.63% 5.82% 6.60% 6.44% 5.56%
Operating Expenses to Revenue		 38.49% 36.70% 37.54% -7.06% 42.02% 48.69% 46.72% 63.30% 74.79% 58.76% 52.91%
Earnings before Interest and Taxes (EBIT)		 15 23 29 37 24 -6.19 8.53 -86 -109 -42 -28
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 29 36 41 48 38 12 30 -63 -91 -21 -7.11
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.88 7.47 10.95 8.61 4.36 2.83 2.09 1.52 0.62 1.26 0.95
Price to Tangible Book Value (P/TBV)		 5.89 7.48 11.30 8.78 6.42 3.99 2.79 1.71 0.80 1.63 1.21
Price to Revenue (P/Rev)		 4.95 6.71 9.96 4.98 2.08 3.20 2.16 1.20 0.41 0.65 0.52
Price to Earnings (P/E)		 68.01 66.32 118.33 6.53 6.97 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 1.47% 1.51% 0.85% 15.30% 14.34% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 13.71 18.28 43.53 34.71 9.55 6.39 4.23 2.40 0.00 1.79 0.86
Enterprise Value to Revenue (EV/Rev)		 4.44 6.15 9.27 4.53 1.79 2.45 1.47 0.70 0.00 0.30 0.18
Enterprise Value to EBITDA (EV/EBITDA)		 24.61 34.55 56.11 50.16 34.16 61.09 17.48 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 48.15 55.34 80.00 65.39 53.82 0.00 61.79 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 59.57 60.40 118.29 50.08 75.76 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 18.48 40.18 38.21 40.55 31.88 20.45 22.30 0.00 0.00 17.08 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 31.58 321.85 66.71 77.01 0.00 86.96 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.55 -0.62 -0.70 -0.77 -0.69 -0.63 -0.66 -0.65 -0.63 -0.65 -0.65
Leverage Ratio		 1.20 1.19 1.20 1.21 1.26 1.31 1.32 1.34 1.46 1.64 1.62
Compound Leverage Factor		 1.20 1.20 1.23 1.32 1.27 1.12 1.34 1.30 1.37 1.44 1.37
Debt to Total Capital		 0.23% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.23% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 99.77% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 -2.88 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 -6.98 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 18.90 27.54 33.19 27.33 11.48 6.78 5.53 3.41 0.49 1.46 1.61
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 5.22 7.07 6.74 6.75 5.82 5.39 5.35 4.66 2.86 2.42 3.12
Quick Ratio		 4.67 6.33 6.06 5.95 4.85 4.60 4.39 3.82 2.35 1.87 2.49
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 22 3.87 35 32 -48 8.71 -13 -45 -43 -9.87 -36
Operating Cash Flow to CapEx		 1,728.31% 2,333.38% 2,215.09% 818.46% 1,376.50% 876.67% 443.48% -1,248.57% -64.42% 191.70% -444.55%
Free Cash Flow to Firm to Interest Expense		 1,015.18 645.75 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 1,734.59 5,172.33 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 1,634.23 4,950.67 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.06 1.08 1.02 1.65 1.76 0.68 0.75 0.84 0.86 1.08 1.17
Accounts Receivable Turnover		 8.11 8.00 8.01 15.67 20.29 9.63 13.22 8.65 6.01 9.35 10.19
Inventory Turnover		 10.18 9.18 7.73 7.82 6.64 5.63 6.40 6.78 6.76 7.76 7.66
Fixed Asset Turnover		 5.08 7.26 11.01 25.29 34.65 12.94 10.66 9.18 6.75 7.09 8.63
Accounts Payable Turnover		 6.86 8.22 7.67 7.57 7.24 5.29 6.11 7.50 5.89 6.32 6.36
Days Sales Outstanding (DSO)		 45.02 45.62 45.56 23.29 17.99 37.89 27.61 42.17 60.69 39.04 35.82
Days Inventory Outstanding (DIO)		 35.87 39.76 47.24 46.67 54.96 64.81 56.99 53.81 54.02 47.05 47.67
Days Payable Outstanding (DPO)		 53.24 44.38 47.58 48.20 50.39 69.06 59.72 48.67 61.92 57.78 57.35
Cash Conversion Cycle (CCC)		 27.65 41.00 45.23 21.76 22.56 33.64 24.89 47.32 52.78 28.30 26.13
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 51 68 53 70 136 118 125 110 76 56 71
Invested Capital Turnover		 2.81 3.39 4.11 8.71 7.04 2.43 2.95 3.21 3.38 5.06 5.46
Increase / (Decrease) in Invested Capital		 -10 17 -15 17 65 -17 6.31 -14 -34 -20 15
Enterprise Value (EV)		 705 1,247 2,311 2,432 1,294 757 527 265 -0.51 101 62
Market Capitalization		 788 1,361 2,485 2,672 1,503 988 773 452 128 218 182
Book Value per Share		 $6.82 $8.99 $10.88 $14.42 $15.67 $15.81 $16.29 $12.98 $8.79 $7.30 $7.08
Tangible Book Value per Share		 $6.81 $8.98 $10.54 $14.14 $10.64 $11.20 $12.19 $11.53 $6.87 $5.62 $5.55
Total Capital		 134 182 227 310 345 350 370 297 205 174 192
Total Debt		 0.32 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -83 -114 -174 -240 -209 -231 -246 -187 -128 -117 -121
Capital Expenditures (CapEx)		 2.21 1.33 2.73 7.33 2.95 4.22 5.33 3.01 5.02 3.09 2.52
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 10 25 21 28 33 18 22 52 6.10 -8.65 14
Debt-free Net Working Capital (DFNWC)		 93 139 195 268 242 249 268 239 135 109 135
Net Working Capital (NWC)		 93 139 195 268 242 249 268 239 135 109 135
Net Nonoperating Expense (NNE)		 0.25 0.13 -1.46 -3.28 -3.87 -2.59 -0.42 24 26 6.13 1.60
Net Nonoperating Obligations (NNO)		 -83 -114 -174 -240 -209 -231 -246 -187 -128 -117 -121
Total Depreciation and Amortization (D&A)		 14 14 12 11 14 19 22 24 18 21 21
Debt-free, Cash-free Net Working Capital to Revenue		 6.44% 12.23% 8.28% 5.15% 4.55% 5.76% 6.19% 13.86% 1.93% -2.58% 3.99%
Debt-free Net Working Capital to Revenue		 58.58% 68.38% 78.02% 49.94% 33.44% 80.71% 74.77% 63.43% 42.63% 32.40% 38.65%
Net Working Capital to Revenue		 58.38% 68.38% 78.02% 49.94% 33.44% 80.71% 74.77% 63.43% 42.63% 32.40% 38.65%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.60 $1.02 $1.02 $2.44 $0.96 ($0.27) ($0.28) ($3.67) ($4.42) ($1.52) ($0.86)
Adjusted Weighted Average Basic Shares Outstanding		 19.40M 20.07M 20.68M 21.27M 21.82M 21.98M 22.49M 22.85M 23.18M 23.65M 26.60M
Adjusted Diluted Earnings per Share		 $0.56 $0.97 $0.96 $2.30 $0.94 ($0.27) ($0.28) ($3.67) ($4.42) ($1.52) ($0.86)
Adjusted Weighted Average Diluted Shares Outstanding		 20.71M 21.10M 21.90M 22.51M 22.24M 21.98M 22.49M 22.85M 23.18M 23.65M 26.60M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 19.85M 20.48M 21.10M 21.81M 22.03M 22.25M 22.49M 22.97M 23.33M 26.53M 27.23M
Normalized Net Operating Profit after Tax (NOPAT)		 12 21 20 27 17 -8.42 6.47 -23 -54 -30 -21
Normalized NOPAT Margin		 7.45% 10.18% 7.83% 4.94% 2.36% -2.73% 1.81% -6.14% -16.96% -8.87% -6.06%
Pre Tax Income Margin		 9.26% 11.20% 11.89% 7.54% 3.35% -1.71% 2.42% -22.07% -32.42% -10.87% -6.71%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 665.77 3,755.83 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 538.18 3,440.75 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 565.41 3,534.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 437.81 3,219.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Inogen

This table displays calculated financial ratios and metrics derived from Inogen's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 23,194,473.00 23,307,814.00 23,326,783.00 23,577,109.00 23,719,012.00 - 26,529,544.00 26,887,242.00 27,040,390.00 27,148,482.00 27,232,350.00
DEI Adjusted Shares Outstanding		 23,194,473.00 23,307,814.00 23,326,783.00 23,577,109.00 23,719,012.00 - 26,529,544.00 26,887,242.00 27,040,390.00 27,148,482.00 27,232,350.00
DEI Earnings Per Adjusted Shares Outstanding		 -1.97 -1.14 -0.62 -0.24 -0.25 - -0.23 -0.15 -0.20 -0.26 -0.31
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -20.33% -13.84% 8.12% 6.13% 5.80% 5.51% 5.45% 3.96% 4.00% 2.05% 3.44%
EBITDA Growth		 -871.32% 54.90% 38.23% 77.75% 95.79% 72.73% 80.57% 86.62% 27.92% 45.62% -111.94%
EBIT Growth		 -357.29% 50.69% 25.59% 39.38% 84.92% 59.92% 54.75% 21.67% 8.37% 25.86% -28.47%
NOPAT Growth		 -353.95% 50.45% 25.74% 39.97% 83.32% 60.71% 52.96% 13.24% 8.68% 18.27% -21.94%
Net Income Growth		 -380.95% 53.09% 28.36% 43.11% 86.96% 63.26% 57.65% 25.72% 11.22% 26.96% -34.82%
EPS Growth		 -369.05% 53.63% 29.55% 42.86% 87.31% 64.35% 59.68% 37.50% 20.00% 36.59% -20.00%
Operating Cash Flow Growth		 123.04% 79.67% 24.63% 65.98% 220.00% 4.13% -253.55% -34.97% -69.01% 68.75% 60.18%
Free Cash Flow Firm Growth		 707.09% 151.70% 119.04% 66.32% 63.28% -13.35% -137.33% -141.18% -163.51% -279.73% 70.49%
Invested Capital Growth		 -34.43% -30.85% -32.45% -36.59% -33.96% -26.06% 4.61% 14.23% 18.84% 26.43% -5.27%
Revenue Q/Q Growth		 0.40% -9.61% 2.81% 13.76% 0.08% -9.85% 2.75% 12.15% 0.12% -11.55% 4.15%
EBITDA Q/Q Growth		 -496.73% 44.60% 53.85% 85.41% -13.00% -258.46% 67.12% 89.96% -508.96% -170.41% -28.16%
EBIT Q/Q Growth		 -312.20% 39.11% 43.77% 57.04% -2.53% -61.86% 36.52% 25.64% -19.93% -30.97% -9.99%
NOPAT Q/Q Growth		 -297.02% 37.97% 43.85% 56.59% -10.31% -46.12% 32.76% 19.95% -16.10% -30.78% -0.32%
Net Income Q/Q Growth		 -365.29% 41.92% 45.10% 61.65% -6.67% -63.63% 36.72% 32.75% -27.50% -34.62% -16.80%
EPS Q/Q Growth		 -369.05% 41.62% 46.09% 61.29% -4.17% -64.00% 39.02% 40.00% -33.33% -30.00% -15.38%
Operating Cash Flow Q/Q Growth		 -45.78% -244.07% -50.86% 240.85% 4.53% -143.16% -456.33% 125.91% -50.18% -143.52% -608.91%
Free Cash Flow Firm Q/Q Growth		 -20.61% -13.51% 68.90% 43.41% -22.06% -54.11% -172.78% -58.20% -20.19% -29.89% 88.05%
Invested Capital Q/Q Growth		 -11.51% -17.55% -5.56% -7.97% -7.84% -7.69% 33.60% 0.50% -4.11% -1.80% 0.10%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 40.21% 37.10% 44.05% 48.15% 46.54% 45.32% 44.21% 44.80% 44.72% 43.12% 44.49%
EBITDA Margin		 -50.62% -31.02% -13.93% -1.79% -2.02% -8.02% -2.57% -0.23% -1.40% -4.27% -5.26%
Operating Margin		 -55.64% -38.19% -20.86% -7.96% -8.77% -14.22% -9.30% -6.64% -7.70% -11.39% -10.97%
EBIT Margin		 -56.12% -37.80% -20.67% -7.81% -8.00% -14.36% -8.87% -5.88% -7.05% -10.43% -11.02%
Profit (Net Income) Margin		 -54.45% -34.99% -18.68% -6.30% -6.71% -12.18% -7.50% -4.50% -5.73% -8.72% -9.78%
Tax Burden Percent		 100.88% 98.03% 98.98% 99.87% 98.33% 96.73% 98.45% 96.45% 97.32% 96.79% 97.95%
Interest Burden Percent		 96.18% 94.42% 91.30% 80.76% 85.35% 87.71% 85.90% 79.31% 83.56% 86.36% 90.62%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -109.24% -90.37% -52.50% -21.29% -26.48% -50.32% -30.02% -22.47% -27.96% -43.49% -36.76%
ROIC Less NNEP Spread (ROIC-NNEP)		 -101.75% -86.40% -50.34% -20.84% -26.09% -48.87% -29.35% -22.58% -27.71% -42.98% -35.23%
Return on Net Nonoperating Assets (RNNOA)		 60.84% 54.27% 31.31% 13.13% 16.45% 31.73% 18.25% 14.29% 18.02% 27.97% 21.65%
Return on Equity (ROE)		 -48.40% -36.10% -21.19% -8.15% -10.03% -18.59% -11.78% -8.18% -9.94% -15.52% -15.11%
Cash Return on Invested Capital (CROIC)		 -41.58% -45.54% -42.48% -36.31% -13.84% -14.86% -36.67% -45.75% -51.00% -56.44% -24.99%
Operating Return on Assets (OROA)		 -45.24% -32.64% -18.96% -7.46% -8.16% -15.49% -9.67% -6.51% -7.98% -12.23% -13.03%
Return on Assets (ROA)		 -43.90% -30.21% -17.13% -6.02% -6.85% -13.14% -8.18% -4.98% -6.49% -10.22% -11.57%
Return on Common Equity (ROCE)		 -48.40% -36.10% -21.19% -8.15% -10.03% -18.59% -11.78% -8.18% -9.94% -15.52% -15.11%
Return on Equity Simple (ROE_SIMPLE)		 -57.45% 0.00% -50.38% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -33 -20 -11 -4.94 -5.45 -7.97 -5.36 -4.29 -4.98 -6.51 -6.54
NOPAT Margin		 -38.95% -26.73% -14.60% -5.57% -6.14% -9.95% -6.51% -4.65% -5.39% -7.97% -7.68%
Net Nonoperating Expense Percent (NNEP)		 -7.49% -3.97% -2.16% -0.44% -0.39% -1.45% -0.67% 0.11% -0.25% -0.51% -1.53%
Return On Investment Capital (ROIC_SIMPLE)		 - -9.91% -5.94% -2.64% -2.94% -4.58% -2.71% -2.15% -2.53% -3.39% -3.57%
Cost of Revenue to Revenue		 59.79% 62.90% 55.95% 51.85% 53.46% 54.68% 55.79% 55.20% 55.28% 56.88% 55.51%
SG&A Expenses to Revenue		 20.26% 32.64% 21.96% 20.92% 21.68% 22.01% 19.73% 18.28% 19.65% 19.73% 20.56%
R&D to Revenue		 5.35% 8.85% 8.43% 6.33% 3.96% 7.37% 4.90% 5.65% 5.24% 6.51% 5.99%
Operating Expenses to Revenue		 95.85% 75.29% 64.91% 56.10% 55.31% 59.53% 53.51% 51.44% 52.42% 54.51% 55.46%
Earnings before Interest and Taxes (EBIT)		 -47 -29 -16 -6.93 -7.11 -12 -7.30 -5.43 -6.51 -8.53 -9.38
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -43 -24 -11 -1.59 -1.79 -6.42 -2.11 -0.21 -1.29 -3.49 -4.47
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.53 0.62 0.98 1.02 1.24 1.26 0.96 0.95 1.12 0.95 0.92
Price to Tangible Book Value (P/TBV)		 0.65 0.80 1.26 1.33 1.63 1.63 1.21 1.22 1.43 1.21 1.17
Price to Revenue (P/Rev)		 0.37 0.41 0.59 0.59 0.69 0.65 0.56 0.55 0.64 0.52 0.48
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.95 1.06 1.73 1.79 0.88 0.86 1.33 0.86 0.80
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.21 0.22 0.32 0.30 0.20 0.19 0.28 0.18 0.16
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 72.09 18.30 17.08 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.60 -0.63 -0.62 -0.63 -0.63 -0.65 -0.62 -0.63 -0.65 -0.65 -0.61
Leverage Ratio		 1.40 1.46 1.48 1.48 1.56 1.64 1.60 1.60 1.60 1.62 1.56
Compound Leverage Factor		 1.35 1.37 1.35 1.19 1.33 1.44 1.38 1.27 1.34 1.40 1.41
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 1.35 1.30 1.66 1.79 1.97 1.79 1.86 1.84 2.04 1.82 1.74
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.73 2.86 2.70 2.70 2.66 2.42 3.07 3.03 3.14 3.12 3.10
Quick Ratio		 3.09 2.35 2.17 2.13 2.14 1.87 2.38 2.40 2.52 2.49 2.47
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 16 14 23 33 26 12 -8.68 -14 -17 -21 -2.56
Operating Cash Flow to CapEx		 333.59% -234.05% -382.98% 74,322.22% 463.05% -925.77% -5,750.00% 635.96% 381.51% -96.32% -3,183.33%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.81 0.86 0.92 0.96 1.02 1.08 1.09 1.11 1.13 1.17 1.18
Accounts Receivable Turnover		 6.63 6.01 6.83 7.49 8.03 9.35 8.85 9.20 9.30 10.19 8.96
Inventory Turnover		 6.69 6.76 6.03 6.85 7.81 7.76 7.20 7.78 7.92 7.66 7.64
Fixed Asset Turnover		 7.27 6.75 6.75 6.79 6.90 7.09 7.52 7.88 8.27 8.63 9.40
Accounts Payable Turnover		 6.25 5.89 5.98 6.90 6.44 6.32 5.42 6.08 6.26 6.36 5.71
Days Sales Outstanding (DSO)		 55.06 60.69 53.42 48.70 45.48 39.04 41.25 39.65 39.24 35.82 40.76
Days Inventory Outstanding (DIO)		 54.56 54.02 60.54 53.30 46.72 47.05 50.67 46.91 46.07 47.67 47.80
Days Payable Outstanding (DPO)		 58.38 61.92 60.99 52.91 56.69 57.78 67.37 60.08 58.29 57.35 63.98
Cash Conversion Cycle (CCC)		 51.24 52.78 52.97 49.09 35.50 28.30 24.56 26.49 27.01 26.13 24.58
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 93 76 72 66 61 56 75 76 73 71 71
Invested Capital Turnover		 2.80 3.38 3.60 3.82 4.31 5.06 4.61 4.83 5.19 5.46 4.79
Increase / (Decrease) in Invested Capital		 -49 -34 -35 -38 -31 -20 3.32 9.44 12 15 -3.97
Enterprise Value (EV)		 -17 -0.51 68 70 106 101 67 65 96 62 57
Market Capitalization		 121 128 188 192 230 218 189 189 221 182 168
Book Value per Share		 $9.94 $8.79 $8.23 $7.96 $7.82 $7.30 $7.46 $7.42 $7.29 $7.08 $6.72
Tangible Book Value per Share		 $8.05 $6.87 $6.39 $6.12 $5.96 $5.62 $5.90 $5.78 $5.71 $5.55 $5.27
Total Capital		 231 205 192 188 185 174 198 199 197 192 183
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -138 -128 -120 -121 -124 -117 -123 -124 -125 -121 -111
Capital Expenditures (CapEx)		 0.66 1.35 1.24 0.01 1.51 0.33 0.29 0.68 0.57 0.98 0.21
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 27 6.10 5.48 1.36 -4.10 -8.65 13 12 14 14 18
Debt-free Net Working Capital (DFNWC)		 165 135 125 123 120 109 135 136 139 135 129
Net Working Capital (NWC)		 165 135 125 123 120 109 135 136 139 135 129
Net Nonoperating Expense (NNE)		 13 6.27 3.19 0.65 0.51 1.79 0.81 -0.14 0.31 0.61 1.79
Net Nonoperating Obligations (NNO)		 -138 -128 -120 -121 -124 -117 -123 -124 -125 -121 -111
Total Depreciation and Amortization (D&A)		 4.61 5.14 5.27 5.35 5.31 5.08 5.19 5.22 5.22 5.04 4.90
Debt-free, Cash-free Net Working Capital to Revenue		 8.19% 1.93% 1.70% 0.42% -1.24% -2.58% 3.74% 3.60% 4.11% 3.99% 5.05%
Debt-free Net Working Capital to Revenue		 50.29% 42.63% 38.97% 37.53% 36.24% 32.40% 39.79% 39.61% 39.99% 38.65% 36.76%
Net Working Capital to Revenue		 50.29% 42.63% 38.97% 37.53% 36.24% 32.40% 39.79% 39.61% 39.99% 38.65% 36.76%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($1.97) ($1.15) ($0.62) ($0.24) ($0.25) ($0.41) ($0.25) ($0.15) ($0.20) ($0.26) ($0.30)
Adjusted Weighted Average Basic Shares Outstanding		 23.23M 23.18M 23.40M 23.61M 23.75M 23.65M 25.16M 26.96M 27.08M 26.60M 27.32M
Adjusted Diluted Earnings per Share		 ($1.97) ($1.15) ($0.62) ($0.24) ($0.25) ($0.41) ($0.25) ($0.15) ($0.20) ($0.26) ($0.30)
Adjusted Weighted Average Diluted Shares Outstanding		 23.23M 23.18M 23.40M 23.61M 23.75M 23.65M 25.16M 26.96M 27.08M 26.60M 27.32M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 23.31M 23.33M 23.58M 23.72M 23.82M 26.53M 26.89M 27.04M 27.15M 27.23M 27.07M
Normalized Net Operating Profit after Tax (NOPAT)		 -9.68 -20 -11 -4.94 -5.45 -7.97 -5.36 -4.29 -4.98 -6.51 -6.54
Normalized NOPAT Margin		 -11.53% -26.73% -14.60% -5.57% -6.14% -9.95% -6.51% -4.65% -5.39% -7.97% -7.68%
Pre Tax Income Margin		 -53.97% -35.69% -18.88% -6.31% -6.83% -12.60% -7.62% -4.67% -5.89% -9.01% -9.98%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Inogen’s latest quarter shows a business that is still unprofitable, but with some balance sheet cushion and a meaningful improvement in operating cash flow versus the weaker periods seen in 2024. Revenue in Q1 2026 rose modestly year over year, while losses narrowed slightly. However, profitability remains elusive, and cash was down sharply from the prior quarter because of negative operating cash flow and ongoing investing activity.

  • Revenue improved year over year. Q1 2026 revenue was $85.1 million, up from $82.3 million in Q1 2025.
  • Gross profit dollar growth outpaced revenue growth. Gross profit increased to $37.9 million from $36.4 million a year ago, suggesting some operating leverage at the product margin level.
  • Cash and investments remain substantial. At March 31, 2026, Inogen held $93.1 million in cash and equivalents plus $17.1 million in short-term investments, giving it liquidity to keep operating.
  • Operating cash flow improved versus early 2024. Over the last several quarters, the company has moved from large cash burn to periods of positive operating cash flow, including Q3 2025 and Q2 2025.
  • Non-cash expenses continue to support reported cash generation. Depreciation and other non-cash items remain meaningful, which helps cushion operating cash flow even when net income is negative.
  • Working-capital swings remain a major driver of quarterly cash flow. Changes in operating assets and liabilities had a large negative impact in Q1 2026, which is one reason cash fell during the quarter.
  • Share count has drifted lower recently. Weighted average shares in Q1 2026 were 27.3 million, down from 27.5 million in the prior quarter range, which can help per-share results if losses narrow.
  • The company is still posting losses. Q1 2026 net loss was $8.3 million, or $0.30 per share, compared with a $7.1 million loss, or $0.26 per share, in Q4 2025.
  • Operating income remains deeply negative. Q1 2026 operating loss was $9.3 million, showing core operations are not yet self-sustaining.
  • Cash declined sharply sequentially. Cash and equivalents fell from $106.5 million in Q3 2025 to $93.1 million in Q1 2026, reflecting continued cash usage.

Longer-term trend: Compared with 2023 and early 2024, Inogen has improved materially from much larger losses and heavier cash burn. In Q3 2023, the company recorded a massive impairment charge and a net loss of $45.7 million. Since then, expense control has improved and impairment charges have disappeared from the recent quarters shown here. Even so, the business is still not consistently profitable, and marketing costs remain a very large share of revenue.

Bottom line: Inogen looks financially stable enough for now thanks to its cash balance, but investors should still view it as a turnaround story. The most encouraging signs are steadier revenue, better gross profit, and improved cash flow relative to the worst periods. The biggest concern is that operating losses are still recurring, so sustained execution will be needed before the stock can justify a more bullish long-term view.

07/07/26 08:30 AM ETAI Generated. May Contain Errors.

Inogen Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Inogen's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Inogen's net income appears to be on an upward trend, with a most recent value of -$22.75 million in 2025, falling from $11.59 million in 2015. The previous period was -$35.89 million in 2024. See where experts think Inogen is headed by visiting Inogen's forecast page.

Inogen's total operating income in 2025 was -$30.21 million, based on the following breakdown:
  • Total Gross Profit: $154.27 million
  • Total Operating Expenses: $184.47 million

Over the last 10 years, Inogen's total revenue changed from $159.01 million in 2015 to $348.67 million in 2025, a change of 119.3%.

Inogen's total liabilities were at $106.39 million at the end of 2025, a 13.0% decrease from 2024, and a 289.8% increase since 2015.

In the past 10 years, Inogen's cash and equivalents has ranged from $66.11 million in 2015 to $235.52 million in 2021, and is currently $103.73 million as of their latest financial filing in 2025.

Over the last 10 years, Inogen's book value per share changed from 6.82 in 2015 to 7.08 in 2025, a change of 3.8%.


Related Companies

Financial statements for NASDAQ:INGN last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel